DHR
Danaher Corporation
NYSE: DHR · HEALTHCARE · DIAGNOSTICS & RESEARCH
$178.95
+0.08% today
Updated 2026-04-29
Market cap
$126.55B
P/E ratio
34.58
P/S ratio
5.11x
EPS (TTM)
$5.17
Dividend yield
0.76%
52W range
$175 – $242
Volume
4.3M
Danaher Corporation (DHR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
14.90%
Operating margin
22.90%
ROE
7.08%
ROA
4.19%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $9.60B | $1.12B | 44.22% | 15.69% | 11.69% |
| 2007 | $11.03B | $1.22B | 45.72% | 15.66% | 11.07% |
| 2008 | $12.70B | $1.32B | 47.04% | 15.37% | 10.38% |
| 2009 | $11.18B | $1.15B | 48.30% | 15.49% | 10.30% |
| 2010 | $13.20B | $1.79B | 50.19% | 16.92% | 13.58% |
| 2011 | $16.09B | $1.97B | 51.24% | 17.01% | 12.25% |
| 2012 | $18.26B | $2.30B | 51.74% | 17.50% | 12.59% |
| 2013 | $19.12B | $2.69B | 52.22% | 17.62% | 14.10% |
| 2014 | $19.91B | $2.60B | 52.67% | 18.09% | 13.05% |
| 2015 | $14.43B | $2.60B | 54.83% | 16.75% | 17.99% |
| 2016 | $16.88B | $2.55B | 55.58% | 17.69% | 15.13% |
| 2017 | $18.33B | $2.49B | 55.81% | 17.18% | 13.60% |
| 2018 | $17.05B | $2.65B | 55.75% | 18.01% | 15.55% |
| 2019 | $17.91B | $2.56B | 55.74% | 18.77% | 14.28% |
| 2020 | $22.28B | $3.65B | 55.98% | 19.35% | 16.36% |
| 2021 | $29.45B | $6.43B | 60.95% | 27.33% | 21.84% |
| 2022 | $26.64B | $7.21B | 60.76% | 28.29% | 27.06% |
| 2023 | $23.89B | $4.74B | 58.74% | 21.77% | 19.85% |
| 2024 | $23.88B | $3.90B | 59.50% | 21.71% | 16.33% |
| 2025 | $24.57B | $3.61B | 60.93% | 20.91% | 14.71% |